Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
High-efficacy therapy 'superior' in reducing relapses, but not delaying disability, in MS
Patients with active secondary progressive MS who received high-efficacy therapy experienced relapses less often than those on low-efficacy therapy, according to findings published in Neurology.
APOE e4 allele impacts changes in Alzheimer’s disease in patients with Down syndrome
The APOE e4 allele correlated with earlier clinical and biomarker-related changes of Alzheimer’s disease among patients with Down syndrome, according to results from a dual-center cohort study published in JAMA Neurology.
Log in or Sign up for Free to view tailored content for your specialty!
Learn the risks, benefits of long-term care planning
A physician’s concerns about long-term care typically increase over time – with many beginning to focus on this type of planning in their 50s or early 60s.
Adding second-line therapy ineffective for seizure cessation in status epilepticus subset
Patients with benzodiazepine-refractory convulsive status epilepticus who received a home medication vs. non-home medication did not differ in cessation of clinical seizures with improved consciousness by 60 minutes after drug initiation.
Home health care after deep brain stimulation safe, effective in Parkinson’s disease
Postoperative home care after deep brain stimulation for Parkinson’s disease demonstrated efficacy, safety and feasibility while also decreasing travel burden, according to results from a single-center study published in JAMA Neurology.
Black patients with MS experience greater disease burden
Black patients with MS experienced a greater burden of disease compared with white patients with MS, even after adjustments for socioeconomic status, according to results published in Neurology.
Viltepso improves motor function in patients with Duchenne muscular dystrophy
Viltepso, an injection treatment for Duchenne muscular dystrophy in patients with a confirmed mutation, demonstrated a statistically significant benefit for motor function in open-label extension results from a phase 2 study.
Exservan now available in the United States for patients with ALS
Exservan, the first oral film formulation of riluzole, has been made available in the United States for the treatment of ALS, according to a press release from Mitsubishi Tanabe Pharma America, the drug’s manufacturer.
Direct thrombectomy, bridging therapy confer similar functional outcomes in stroke
Results of a meta-analysis published in Neurology determined there was no difference in functional outcomes between direct thrombectomy and combination with bridging IV thrombolysis among Asian patients with large vessel occlusion stroke.
Q&A: AAPA seeks 'physician associate' title change despite opposition from AMA
In a 198 to 68 vote, members of the American Academy of Physician Assistants’ House of Delegates passed a resolution to change the title of physician assistants to “physician associates.”
-
Headline News
GLP-1 therapy may reduce suicidal ideation risk for adolescents with obesity
October 14, 20242 min read -
Headline News
Dietary supplement evidence 'varies widely' with inconsistent regulations
October 14, 20249 min read -
Headline News
Beer, ciders increase gout risk in men and women more than other alcohol types
October 14, 20242 min read
-
Headline News
GLP-1 therapy may reduce suicidal ideation risk for adolescents with obesity
October 14, 20242 min read -
Headline News
Dietary supplement evidence 'varies widely' with inconsistent regulations
October 14, 20249 min read -
Headline News
Beer, ciders increase gout risk in men and women more than other alcohol types
October 14, 20242 min read